Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
1.120
+0.010 (0.90%)
Aug 14, 2025, 2:09 PM - Market open

Autonomix Medical Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
8.599.148.610.872.04
Cash & Short-Term Investments
8.599.148.610.872.04
Cash Growth
27.23%6.13%895.14%-57.68%-
Other Current Assets
0.390.470.78-0.01
Total Current Assets
8.989.619.390.872.05
Property, Plant & Equipment
0.020.020.02--
Long-Term Deferred Charges
-0.18---
Total Assets
99.819.410.872.05
Accounts Payable
0.820.680.490.170.09
Accrued Expenses
1.151.030.290.050
Total Current Liabilities
1.971.710.780.220.09
Long-Term Debt
--1--
Total Liabilities
1.971.711.780.220.09
Common Stock
0000.010.01
Additional Paid-In Capital
60.7458.4846.624.1823.5
Retained Earnings
-53.72-50.38-38.97-23.54-21.55
Shareholders' Equity
7.038.17.630.641.96
Total Liabilities & Equity
99.819.410.872.05
Total Debt
--1--
Net Cash (Debt)
8.599.147.610.872.04
Net Cash Growth
50.47%20.12%779.31%-57.68%-
Net Cash Per Share
3.845.177.311.4419.73
Filing Date Shares Outstanding
5.152.780.940.890.1
Total Common Shares Outstanding
4.022.50.940.620.1
Working Capital
7.017.98.610.641.96
Book Value Per Share
1.753.248.101.0418.91
Tangible Book Value
7.038.17.630.641.96
Tangible Book Value Per Share
1.753.248.101.0418.91
Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q